Driehaus Capital Management LLC Amgen Inc Transaction History

Driehaus Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $224,760 - $253,556	879 New	879 $253,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $31.8 Million - $35.4 Million	-137,830 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $30.2 Million - $33.4 Million	137,830 New	137,830 $33.3 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $297,350 - $335,178	-1,644 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $3,568 - $4,165	-20 Reduced 1.2%	1,644 $320,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $106,727 - $120,320	576 Added 52.94%	1,664 $345,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $51,641 - $58,004	-311 Reduced 22.23%	1,088 $201,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $47,609 - $55,638	-281 Reduced 16.73%	1,399 $239,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $281,047 - $320,880	1,680	1,680 $313,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.